KIF1C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.369600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.920800E-01
Normal-vs-Stage2
9.432600E-01
Normal-vs-Stage3
4.986200E-01
Normal-vs-Stage4
8.791600E-01
Stage1-vs-Stage2
4.091000E-01
Stage1-vs-Stage3
8.431000E-01
Stage1-vs-Stage4
5.935000E-01
Stage2-vs-Stage3
3.571800E-01
Stage2-vs-Stage4
9.231600E-01
Stage3-vs-Stage4
4.338800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.833800E-01
Normal-vs-AfricanAmerican
7.545400E-01
Normal-vs-Asian
9.054600E-01
Caucasian-vs-AfricanAmerican
3.347200E-01
Caucasian-vs-Asian
4.351800E-01
AfricanAmerican-vs-Asian
7.788200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.271800E-01
Normal-vs-Female
8.294000E-01
Male-vs-Female
9.302000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.597400E-01
Normal-vs-Age(41-60Yrs)
9.734600E-01
Normal-vs-Age(61-80Yrs)
7.399400E-01
Normal-vs-Age(81-100Yrs)
9.751400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.327600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.563200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.402800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.871380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.023600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.547000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.859200E-01
Normal-vs-Daily Drinker
5.986200E-01
Normal-vs-Weekly Drinker
5.006800E-01
Normal-vs-Occasional Drinker
7.810200E-01
Normal-vs-Social Drinker
9.527200E-01
Non Drinker-vs-Daily Drinker
4.340000E-01
Non Drinker-vs-Weekly Drinker
1.241420E-01
Non Drinker-vs-Occasional Drinker
7.722000E-01
Non Drinker-vs-Social Drinker
8.959600E-01
Daily Drinker-vs-Weekly Drinker
3.084200E-02
Daily Drinker-vs-Occasional Drinker
6.760400E-01
Daily Drinker-vs-Social Drinker
4.533800E-01
Weekly Drinker-vs-Occasional Drinker
1.012360E-01
Weekly Drinker-vs-Social Drinker
2.560200E-01
Occasional Drinker-vs-Social Drinker
7.287600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.435600E-01
Normal-vs-Grade 2
9.814600E-01
Normal-vs-Grade 3
9.790200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.117720E-02
Grade 1-vs-Grade 3
4.880000E-02
Grade 1-vs-Grade 4
8.435600E-01
Grade 2-vs-Grade 3
4.156200E-01
Grade 2-vs-Grade 4
9.814600E-01
Grade 3-vs-Grade 4
9.790200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.133400E-01
Normal-vs-NonDiabetic
8.105000E-01
Diabetic-vs-NonDiabetic
8.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.817600E-01
Normal-vs-NoPancreatitis
7.344600E-01
Pancreatitis-vs-NoPancreatitis
8.037600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.703600E-01
Normal-vs-N1
8.948400E-01
N0-vs-N1
4.810600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.913000E-01
Normal-vs-TP53-NonMutant
5.816400E-01
TP53-Mutant-vs-TP53-NonMutant
9.790800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
